About: Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1996 (uk) article scientifique publié en 1996 (fr) im Juli 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 1996 (ast) scientific article published on 01 July 1996 (en)
publication date	wds:Q71219727-A2BAF93A-08BE-4F4A-B825-031A8DB065FA
publication date	1996-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71219727-CF1C47F6-4966-4CF1-9D5F-22925A9400E1
language of work or name	English
cites work	wds:Q71219727-101B2AF9-63AB-441B-B03F-64282CA321DD wds:Q71219727-79F7DFE9-ECCF-4DDA-915A-837695E04A2C wds:Q71219727-8877DB4B-BE59-420D-8C65-61257AEFB113 wds:Q71219727-97CE4038-2A3B-4BD9-955E-B61C9B241BCB wds:Q71219727-C80C2220-85EC-4EB2-94EE-C08AD2107BF5 wds:Q71219727-D2C3EDA1-158C-4E13-85F4-337C43757DD1
cites work	A placebo controlled trial of fluticasone propionate in asthmatic children Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler Acute adrenal insufficiency associated with high dose inhaled steroids The human pharmacology of fluticasone propionate Inhaled corticosteroid therapy in children: an assessment of the potential for side effects
author name string	wds:Q71219727-4284D364-7EFB-49AA-B4A6-7605C50877BA wds:Q71219727-53CDAB34-5C83-454F-969A-3CA4163C7A71 wds:Q71219727-A359DEC1-8580-44C7-9F8E-396547886AF1 wds:Q71219727-CCE40C4E-170F-40E3-8A80-A360AD3F2AD0 wds:Q71219727-D3E6D127-7DB1-4A14-88FC-83CF6F15C9CA wds:Q71219727-FA3CDB43-08F7-48CB-A79B-C5EB6CD545D7
author name string	D Carson M F Ryan G Todd M D Shields J McNaboe K Dunlop
rdfs:label	Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate (en) Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate (nl)
skos:prefLabel	Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate (en) Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate (nl)
name	Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate (en) Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate (nl)
title	wds:Q71219727-B0BF05D0-24F9-4A3C-82DC-6FD08BDF250F
title	Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate (en)
page(s)	wds:Q71219727-D41221CA-4F61-4BE8-84F0-4FC4A910F496
page(s)	27-29
instance of	wds:Q71219727-8F9FCF71-1CDC-447E-BD19-D52512B2DA3E
instance of	scholarly article
main subject	wds:Q71219727-7C40FC19-3142-4803-839A-1448764374D4 wds:Q71219727-DD7D396F-C389-4E4A-93C4-6CAFC5B0B38A
main subject	asthma fluticasone propionate
PubMed ID	wds:Q71219727-35D76CB8-2C39-4D5B-9309-1C9A5B4A50CD
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8691927
PubMed ID	8691927
published in	wds:Q71219727-04B11E9A-A6CF-4470-961D-1A95F84B4F5B
published in	The Lancet
issue	wds:Q71219727-49FF629C-F1BC-4B60-BE91-93A627EFEF62
volume	wds:Q71219727-C4C2C426-B610-496C-AF47-FA4734FEAAAA
issue	9019
volume	348
DOI	wds:Q71219727-81F5FBDA-084A-44B8-AA41-BEA0DA7F6480
DOI	http://dx.doi.org/10.1016/S0140-6736(96)03339-9
DOI	10.1016/S0140-6736(96)03339-9
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71219727
is cites work of	Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis. Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group Safety of inhaled corticosteroids in the treatment of persistent asthma. Efficacy of anti-LT agents in the treatment of chronic asthma Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children Drug use in children: cohort study in three European countries Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom Safety of the newer inhaled corticosteroids in childhood asthma Asthma treatment and growth Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate Adrenal suppression secondary to inhaled fluticasone propionate. Inhaled corticosteroids for non-specific chronic cough in children Inhaled corticosteroids for cystic fibrosis Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children Safety of inhaled and intranasal corticosteroids: lessons for the new millennium Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma Monitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone Clinical and biological heterogeneity in children with moderate asthma Impaired recovery of hypothalamic-pituitary-adrenal axis function and hypoglycemic seizures after high-dose inhaled corticosteroid therapy in a toddler Acute adrenal insufficiency in a patient with asthma after changing from fluticasone propionate to budesonide Suppression of HPA axis in adults taking inhaled corticosteroids Inhaled corticosteroids for cystic fibrosis Antiasthmatic drug delivery in children Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids Current recommendations for the treatment of mild asthma Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology Assessment of adrenal suppression in children with asthma treated with inhaled corticosteroids: use of dehydroepiandrosterone sulfate as a screening test. Inhaled steroids in children: risks versus rewards Prescribed doses of inhaled steroids in Dutch children: too little or too much, for too short a time High-dose inhaled steroids in asthmatic children Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma [Inhaled glucocorticoids and their effects on growth in children] High-dose inhaled steroids in asthmatic children New approaches to anti-inflammatory therapy for asthma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software